share_log

Prime Medicine | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Prime Medicine | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Prime Medicine | PRE 14A:并购重组委托声明
美股sec公告 ·  04/19 16:10
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息